{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:09:03Z","timestamp":1792120143674,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003358"],"award-info":[{"award-number":["82003358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"crossref","award":["2021YFS0078"],"award-info":[{"award-number":["2021YFS0078"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC1005300"],"award-info":[{"award-number":["2021YFC1005300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oculocutaneous albinism (OCA) is a group of heterogeneous genetic diseases characterized by a reduction or complete lack of pigmentation in the hair, skin, and eyes. It is associated with reduced visual acuity, nystagmus, photophobia, and strabismus. OCA type 1 (OCA1) and type 2 (OCA2) are caused by mutations in the tyrosinase (<jats:italic>TYR<\/jats:italic>) and <jats:italic>OCA2<\/jats:italic> genes, which are responsible for most cases of OCA. The present study aimed to identify the mutational spectra of 18 southwest Chinese probands with OCA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We used a skin disease-targeted panel to sequence more than 400 genes, including 23 genes (<jats:italic>TYR<\/jats:italic>, <jats:italic>OCA2<\/jats:italic>, <jats:italic>AP3B1<\/jats:italic>, <jats:italic>BLOC1S3<\/jats:italic>, <jats:italic>BLOC1S6<\/jats:italic>, <jats:italic>C10orf11<\/jats:italic>, <jats:italic>DTNBP1<\/jats:italic>, <jats:italic>FRMD7<\/jats:italic>, <jats:italic>GPR143<\/jats:italic>, <jats:italic>HPS1<\/jats:italic>, <jats:italic>HPS3<\/jats:italic>, <jats:italic>HPS4<\/jats:italic>, <jats:italic>HPS5<\/jats:italic>, <jats:italic>HPS6<\/jats:italic>, <jats:italic>LYST<\/jats:italic>, <jats:italic>MC1R<\/jats:italic>, <jats:italic>MITF<\/jats:italic>, <jats:italic>MLPH<\/jats:italic>, <jats:italic>MYO5A<\/jats:italic>, <jats:italic>RAB27A<\/jats:italic>, <jats:italic>SLC24A5<\/jats:italic>, <jats:italic>SLC45A2<\/jats:italic>, <jats:italic>TYRP1<\/jats:italic>) associated with syndromic and non-syndromic albinism. The targeted panel was applied to 18 patients from southwest China, nine (50%) patients were diagnosed with OCA1, and nine (50%) were diagnosed with OCA2. Our data indicate that OCA1 and OCA2, the most common subtypes, probably have the same prevalence in southwest China. In total, we identified 26 variants in <jats:italic>TYR<\/jats:italic> and <jats:italic>OCA2<\/jats:italic> from 18 OCA cases using the NGS technology, including 24 variants presented in the Human Gene Mutation Database Professional (HGMD) and two novel variants, c.559_560insCATTATTATGTGTCAAATTATCCCC in <jats:italic>TYR<\/jats:italic> and c.1514\u00a0T\u2009&gt;\u2009C in <jats:italic>OCA2<\/jats:italic>, which have not been previously reported. According to the American College of Medical Genetics and Genomics (ACMG) classification, c.559_560insCATTATTATGTGTCAAATTATCCCC (p.G190Cfs*12) is classified as a pathogenic variant, and c.1514\u00a0T\u2009&gt;\u2009C (p.F505S) is evaluated as a likely pathogenic variant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Two novel variants were identified which will expand the mutational spectra of <jats:italic>TYR<\/jats:italic> and <jats:italic>OCA2<\/jats:italic>. The results of the present study may have implications for genetic counseling, carrier screening, and clinical management of the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12864-022-08597-3","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T20:26:55Z","timestamp":1651264015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuanyuan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"8597_CR1","volume":"2014","author":"B Kamaraj","year":"2014","unstructured":"Kamaraj B, Purohit R. Mutational analysis of oculocutaneous albinism: a compact review. Biomed Res Int. 2014;2014: 905472.","journal-title":"Biomed Res Int"},{"issue":"2","key":"8597_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/pcmr.12051","volume":"26","author":"AH Wei","year":"2013","unstructured":"Wei AH, Li W. Hermansky-Pudlak syndrome: pigmentary and non-pigmentary defects and their pathogenesis. Pigment Cell Melanoma Res. 2013;26(2):176\u201392.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"8597_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccm.2016.04.012","volume":"37","author":"S El-Chemaly","year":"2016","unstructured":"El-Chemaly S, Young LR. Hermansky-Pudlak Syndrome. Clin Chest Med. 2016;37(3):505\u201311.","journal-title":"Clin Chest Med"},{"issue":"7\u20138 Pt 1","key":"8597_CR4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.lpm.2017.05.020","volume":"46","author":"B Arveiler","year":"2017","unstructured":"Arveiler B, Lasseaux E, Morice-Picard F. Clinical and genetic aspects of albinism. Presse Med. 2017;46(7\u20138 Pt 1):648\u201354.","journal-title":"Presse Med"},{"issue":"5","key":"8597_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1755-148X.2008.00496.x","volume":"21","author":"C Rooryck","year":"2008","unstructured":"Rooryck C, Morice-Picard F, Elcioglu NH, Lacombe D, Taieb A, Arveiler B. Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell Melanoma Res. 2008;21(5):583\u20137.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"8597_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/jid.2009.339","volume":"130","author":"A Wei","year":"2010","unstructured":"Wei A, Wang Y, Long Y, Wang Y, Guo X, Zhou Z, Zhu W, Liu J, Bian X, Lian S, et al. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism. J Invest Dermatol. 2010;130(3):716\u201324.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"8597_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jgg.2015.05.001","volume":"42","author":"AH Wei","year":"2015","unstructured":"Wei AH, Zang DJ, Zhang Z, Yang XM, Li W. Prenatal genotyping of four common oculocutaneous albinism genes in 51 Chinese families. J Genet Genomics. 2015;42(6):279\u201386.","journal-title":"J Genet Genomics"},{"issue":"4","key":"8597_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/pcmr.12688","volume":"31","author":"E Lasseaux","year":"2018","unstructured":"Lasseaux E, Plaisant C, Michaud V, Pennamen P, Trimouille A, Gaston L, Monferme S, Lacombe D, Rooryck C, Morice-Picard F, et al. Molecular characterization of a series of 990 index patients with albinism. Pigment Cell Melanoma Res. 2018;31(4):466\u201374.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"8597_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/pcmr.12800","volume":"32","author":"K Okamura","year":"2019","unstructured":"Okamura K, Hayashi M, Abe Y, Kono M, Nakajima K, Aoyama Y, Nishigori C, Ishimoto H, Ishimatsu Y, Nakajima M, et al. NGS-based targeted resequencing identified rare subtypes of albinism: Providing accurate molecular diagnosis for Japanese patients with albinism. Pigment Cell Melanoma Res. 2019;32(6):848\u201353.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"8597_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/pcmr.12534","volume":"29","author":"A Wei","year":"2016","unstructured":"Wei A, Yuan Y, Bai D, Ma J, Hao Z, Zhang Y, Yu J, Zhou Z, Yang L, Yang X, et al. NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patients. Pigment Cell Melanoma Res. 2016;29(6):702\u20136.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"8597_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1167\/iovs.10-6091","volume":"52","author":"A Gargiulo","year":"2011","unstructured":"Gargiulo A, Testa F, Rossi S, Di Iorio V, Fecarotta S, de Berardinis T, Iovine A, Magli A, Signorini S, Fazzi E, et al. Molecular and clinical characterization of albinism in a large cohort of Italian patients. Invest Ophthalmol Vis Sci. 2011;52(3):1281\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"8597_CR12","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/jid.2008.109","volume":"128","author":"SM Hutton","year":"2008","unstructured":"Hutton SM, Spritz RA. Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type. J Invest Dermatol. 2008;128(10):2442\u201350.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"8597_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2133.2010.09830.x","volume":"163","author":"M Sengupta","year":"2010","unstructured":"Sengupta M, Mondal M, Jaiswal P, Sinha S, Chaki M, Samanta S, Ray K. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene. Br J Dermatol. 2010;163(3):487\u201394.","journal-title":"Br J Dermatol"},{"issue":"1","key":"8597_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40001-017-0262-0","volume":"22","author":"B Fabos","year":"2017","unstructured":"Fabos B, Farkas K, Toth L, Sulak A, Tripolszki K, Tihanyi M, Nemeth R, Vas K, Csoma Z, Kemeny L, et al. Delineating the genetic heterogeneity of OCA in Hungarian patients. Eur J Med Res. 2017;22(1):20.","journal-title":"Eur J Med Res"},{"issue":"5\u20136","key":"8597_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s004390050568","volume":"100","author":"N Puri","year":"1997","unstructured":"Puri N, Durbam-Pierre D, Aquaron R, Lund PM, King RA, Brilliant MH. Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 27-kb deletion allele of the P gene. Hum Genet. 1997;100(5\u20136):651\u20136.","journal-title":"Hum Genet"},{"issue":"Suppl 8","key":"8597_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1034\/j.1600-0749.13.s8.23.x","volume":"13","author":"Y Tomita","year":"2000","unstructured":"Tomita Y, Miyamura Y, Kono M, Nakamura R, Matsunaga J. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan. Pigment Cell Res. 2000;13(Suppl 8):130\u20134.","journal-title":"Pigment Cell Res"},{"issue":"1","key":"8597_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10038-002-8648-3","volume":"47","author":"M Tanita","year":"2002","unstructured":"Tanita M, Matsunaga J, Miyamura Y, Dakeishi M, Nakamura E, Kono M, Shimizu H, Tagami H, Tomita Y. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis. J Hum Genet. 2002;47(1):1\u20136.","journal-title":"J Hum Genet"},{"issue":"1","key":"8597_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/02713683.2020.1781192","volume":"46","author":"Z Chuan","year":"2021","unstructured":"Chuan Z, Yan Y, Hao S, Zhang Q, Zhou B, Feng X, Wang X, Liu F, Zheng L, Cao Z, et al. Mutation Analysis of 63 Northwest Chinese Probands with Oculocutaneous Albinism. Curr Eye Res. 2021;46(1):140\u20133.","journal-title":"Curr Eye Res"},{"issue":"1","key":"8597_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10384-011-0098-z","volume":"56","author":"SH Park","year":"2012","unstructured":"Park SH, Chae H, Kim Y, Kim M. Molecular analysis of Korean patients with oculocutaneous albinism. Jpn J Ophthalmol. 2012;56(1):98\u2013103.","journal-title":"Jpn J Ophthalmol"},{"issue":"7","key":"8597_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.687","volume":"7","author":"Y Lin","year":"2019","unstructured":"Lin Y, Chen X, Yang Y, Che F, Zhang S, Yuan L, Wu Y. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism. Mol Genet Genomic Med. 2019;7(7): e00687.","journal-title":"Mol Genet Genomic Med"},{"issue":"9","key":"8597_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106656","volume":"9","author":"V Ghodsinejad Kalahroudi","year":"2014","unstructured":"Ghodsinejad Kalahroudi V, Kamalidehghan B, Arasteh Kani A, Aryani O, Tondar M, Ahmadipour F, Chung LY, Houshmand M. Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1). PLoS ONE. 2014;9(9): e106656.","journal-title":"PLoS ONE"},{"issue":"1","key":"8597_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3349\/ymj.2010.51.1.104","volume":"51","author":"JH Lee","year":"2010","unstructured":"Lee JH, Park Y, Choi JR, Lee EK, Kim HS. Comparisons of three automated systems for genomic DNA extraction in a clinical diagnostic laboratory. Yonsei Med J. 2010;51(1):104\u201310.","journal-title":"Yonsei Med J"},{"issue":"4","key":"8597_CR23","first-page":"3271","volume":"22","author":"C Zhou","year":"2020","unstructured":"Zhou C, Xiao Y, Xie H, Liu S, Wang J. A novel variant in ALMS1 in a patient with Alstrom syndrome and prenatal diagnosis for the fetus in the family: A case report and literature review. Mol Med Rep. 2020;22(4):3271\u20136.","journal-title":"Mol Med Rep"},{"issue":"5","key":"8597_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-022-08597-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-022-08597-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-022-08597-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T20:27:04Z","timestamp":1651264024000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-022-08597-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["8597"],"URL":"https:\/\/doi.org\/10.1186\/s12864-022-08597-3","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of West China Second University Hospital of Sichuan University for experiments involving humans. Written informed consent was obtained from all participants or their legal guardians. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent of consent for publication of this study was obtained from all participants or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}